Kostis J B, Goodking M J, Gotzoyannis S, Gerber N H, Kuo P T
Am Heart J. 1977 Dec;94(6):764-8. doi: 10.1016/s0002-8703(77)80218-4.
The effect of lidocaine on the atrial fibrillation threshold (AFT) and the ventricular fibrillation threshold (VFT) was studied in anesthetized dogs. In ten animals, injection of lidocaine 2 mg./Kg. intravenously resulted in a markded increase of the ventricular fibrillation threshold (from 11.0 +/- 1.5 to 33.3 +/- 6.2 mA., P less than 0.001). In another group of ten animals, lidocaine did not have consistent effect on the atrial fibrillation threshold. However, a dose of lidocaine of 3 mg./Kg intravenously produced a significant increase in AFT (from 14.0 +/- 0.56 to 41.1 +/- 0.32 mA., P less than 0.001). No changes in AFT or VFT were noted in control experiments. The data suggest that lidocaine possesses an antiarrhythmic effect on the atria but higher than usual doses are required.
在麻醉犬身上研究了利多卡因对房颤阈值(AFT)和室颤阈值(VFT)的影响。在10只动物中,静脉注射2mg/kg利多卡因导致室颤阈值显著升高(从11.0±1.5毫安升至33.3±6.2毫安,P<0.001)。在另一组10只动物中,利多卡因对房颤阈值没有一致的影响。然而,静脉注射3mg/kg的利多卡因剂量可使AFT显著升高(从14.0±0.56毫安升至41.1±0.32毫安,P<0.001)。在对照实验中未观察到AFT或VFT的变化。数据表明,利多卡因对心房具有抗心律失常作用,但需要高于常规剂量。